Related posts
Markets sink on tech earnings23 Stock Top Picks and 3 ETF (Jan 25-31)Earning Reports to Watch (Jan 7-11)This summary was created by AI, based on 3 opinions in the last 12 months.
Velan Inc (VLN-T) has garnered mixed reviews following the recent thwarted acquisition attempt by an American firm that the French government blocked. Experts highlight the company's strong position as a leader in the nuclear valves market, which remains its core competency. While the stock has experienced volatility—particularly in light of takeover talks—the company is viewed as valuable due to its backlog and growing margins. Analysts believe it trades below its tangible book value, suggesting potential for future gains as the family still seeks a sale. Some reviews indicate a sense of deep value and are optimistic about the stock's long-term prospects if investors remain patient.
They remain the leader in nuclear valves. Shockingly, the French government blocked an American company from buying this small Montreal company. So, the family decided to sell the company and he expects it will be at a higher price. Their backlog and margins are growing. He still owns it. Trades below tangible book value.
Chart looks the way it does because acquisition of its very lucrative nuclear valve business by an American buyer was blocked by the French government. Illiquid stock. The family still wants to sell. Deep value, good return if patient.
It makes high quality valves for the nuclear industry. It had a take-over offer of $13 a share and he sold at around $12.50. However there were worries that the French Government might block the sale so the stock price dropped. The nuclear valves division is based in France. However he feels that the deal will go through in the next few months at $13.00 so has been buying it back as a short-term investment with up to 30% upside.
Buy 1 Hold 0 Sell 0
At this late stage, there won't be another offer, so you'll have to be happy with $13. Should have received a much higher price. Asbestos litigation costs did them in.
The litigation costs over asbestos content have been increasing and eating into profits. It is a jewel of a company and should be worth more than the present offer. There is the possibility of a higher offer.
Lead in their business. Just completed a successful turnaround and enjoying strong sales and a record backlog. Cheap, trading at under a third of book value. Expects a strong next quarter, and that's when the company should sell itself. He's pushing for a sale.
Velan Inc is a Canadian stock, trading under the symbol VLN-T on the Toronto Stock Exchange (VLN-CT). It is usually referred to as TSX:VLN or VLN-T
In the last year, 2 stock analysts published opinions about VLN-T. 1 analyst recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Velan Inc.
Velan Inc was recommended as a Top Pick by on . Read the latest stock experts ratings for Velan Inc.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
2 stock analysts on Stockchase covered Velan Inc In the last year. It is a trending stock that is worth watching.
On 2025-03-21, Velan Inc (VLN-T) stock closed at a price of $16.15.
Bought in just before the takeout deal was nixed by the French government. Rocket ride lately on the nuclear bid hype, so he sold. De facto world gold standard in nuclear valves. Cheap vs. tangible book value. May buy again if cheap enough. Sees eventual takeover.